BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 27575998)

  • 1. The many roles of molecular complexity in drug discovery.
    Méndez-Lucio O; Medina-Franco JL
    Drug Discov Today; 2017 Jan; 22(1):120-126. PubMed ID: 27575998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A data mining method to facilitate SAR transfer.
    Wassermann AM; Bajorath J
    J Chem Inf Model; 2011 Aug; 51(8):1857-66. PubMed ID: 21774471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling of activity landscapes for drug discovery.
    Bajorath J
    Expert Opin Drug Discov; 2012 Jun; 7(6):463-73. PubMed ID: 22475223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SAR Matrix Method for Large-Scale Analysis of Compound Structure-Activity Relationships and Exploration of Multitarget Activity Spaces.
    Hu Y; Bajorath J
    Methods Mol Biol; 2018; 1825():339-352. PubMed ID: 30334212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ligand efficiency and lead optimization].
    Guo ZR
    Yao Xue Xue Bao; 2013 Dec; 48(12):1755-62. PubMed ID: 24689231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complex molecules: do they add value?
    Selzer P; Roth HJ; Ertl P; Schuffenhauer A
    Curr Opin Chem Biol; 2005 Jun; 9(3):310-6. PubMed ID: 15939334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the relationship between topology and selectivity for druglike molecules.
    Yang Y; Chen H; Nilsson I; Muresan S; Engkvist O
    J Med Chem; 2010 Nov; 53(21):7709-14. PubMed ID: 20942392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of ligand efficiency metrics in drug discovery.
    Hopkins AL; Keserü GM; Leeson PD; Rees DC; Reynolds CH
    Nat Rev Drug Discov; 2014 Feb; 13(2):105-21. PubMed ID: 24481311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Escape from flatland: increasing saturation as an approach to improving clinical success.
    Lovering F; Bikker J; Humblet C
    J Med Chem; 2009 Nov; 52(21):6752-6. PubMed ID: 19827778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capturing structure-activity relationships from chemogenomic spaces.
    Wendt B; Uhrig U; Bös F
    J Chem Inf Model; 2011 Apr; 51(4):843-51. PubMed ID: 21410249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction methods and databases within chemoinformatics: emphasis on drugs and drug candidates.
    Jónsdóttir SO; Jørgensen FS; Brunak S
    Bioinformatics; 2005 May; 21(10):2145-60. PubMed ID: 15713739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Making every SAR point count: the development of Chemistry Connect for the large-scale integration of structure and bioactivity data.
    Muresan S; Petrov P; Southan C; Kjellberg MJ; Kogej T; Tyrchan C; Varkonyi P; Xie PH
    Drug Discov Today; 2011 Dec; 16(23-24):1019-30. PubMed ID: 22024215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From activity cliffs to activity ridges: informative data structures for SAR analysis.
    Vogt M; Huang Y; Bajorath J
    J Chem Inf Model; 2011 Aug; 51(8):1848-56. PubMed ID: 21761918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel chemical space exploration via natural products.
    Rosén J; Gottfries J; Muresan S; Backlund A; Oprea TI
    J Med Chem; 2009 Apr; 52(7):1953-62. PubMed ID: 19265440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compound Data Mining for Drug Discovery.
    Bajorath J
    Methods Mol Biol; 2017; 1526():247-256. PubMed ID: 27896746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active-learning strategies in computer-assisted drug discovery.
    Reker D; Schneider G
    Drug Discov Today; 2015 Apr; 20(4):458-65. PubMed ID: 25499665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanding the medicinally relevant chemical space with compound libraries.
    López-Vallejo F; Giulianotti MA; Houghten RA; Medina-Franco JL
    Drug Discov Today; 2012 Jul; 17(13-14):718-26. PubMed ID: 22515962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How do we optimize chemical space navigation?
    Vogt M
    Expert Opin Drug Discov; 2020 May; 15(5):523-525. PubMed ID: 32067507
    [No Abstract]   [Full Text] [Related]  

  • 19. Improvement in aqueous solubility in small molecule drug discovery programs by disruption of molecular planarity and symmetry.
    Ishikawa M; Hashimoto Y
    J Med Chem; 2011 Mar; 54(6):1539-54. PubMed ID: 21344906
    [No Abstract]   [Full Text] [Related]  

  • 20. Large compound databases for structure-activity relationships studies in drug discovery.
    Scior T; Bernard P; Medina-Franco JL; Maggiora GM
    Mini Rev Med Chem; 2007 Aug; 7(8):851-60. PubMed ID: 17692047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.